This disruptive technology arose out of a need identified in daily clinical practice by medical professionals in Osakidetza (the Basque Health System) and who are linked to its Health Research Institute, IIS Biogipuzkoa; it led to collaboration with nanoGUNE and seeks to achieve a solution to improve the monitoring of babies' vital signs –including perinatal asphyxia or lack of oxygen– during childbirth.